Personalized reports accessible through your app to guide your progress
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence
Currently, there are other dual GIPR/GLP-1R agonists available, such as GLP-1R/GR (glucagon receptor), GLP-1R/AR (amylin receptor), and GLP-1R/NPYR (peptide YY binds to neuropeptide Y receptors) [36, 115] and even triple agonists that can activate GIPR to treat obesity and T2DM
Tip: If you take cholesterol-lowering statins like simvastatin or atorvastatin, grapefruit can significantly amplify drug levels in your bloodstream
Phase 2 trials produced an average of 24.2% body weight reduction at the 12mg dose over 48 weeks
Understanding Inflammation Inflammation is the bodys response to injury, infection, toxins, and stress